ALLOGENE THERAPEUTICS INC (ALLO) Stock Cash Flow
NASDAQ:ALLO - Nasdaq - US0197701065 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -252.32M | -257.59M | -327.26M | -332.63M | -257.01M | |||
| Depreciation Amortization | 13.18M | 13.64M | 14.20M | 14.30M | 10.45M | |||
| Change In Working Capital | -28.65M | -24.80M | -15.30M | 3.71M | -32.09M | |||
| Other non cash items | 70.46M | 68.45M | 90.64M | 94.11M | 93.83M | |||
| OPERATING CASH FLOW | -197.33M | -200.30M | -237.73M | -220.52M | -184.81M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -785.00K | -694.00K | -1.52M | -5.19M | -21.45M | |||
| Other Investing Activity | 60.52M | 76.38M | 164.81M | 111.35M | 185.10M | |||
| INVESTING CASH FLOW | 59.73M | 75.69M | 163.29M | 106.16M | 163.66M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 123.39M | 114.39M | 95.69M | 2.95M | 11.96M | |||
| Other Financing Activity | N/A | 2.28M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 129.01M | 116.67M | 95.69M | 2.95M | 11.96M | |||
| CHANGE IN CASH | -8.58M | -7.94M | 21.25M | -111.41M | -9.19M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -197.33M | -200.30M | -237.73M | -220.52M | -184.81M | |||
| Capital Expenditure | -785.00K | -694.00K | -1.52M | -5.19M | -21.45M | |||
| FREE CASH FLOW | -198.12M | -200.99M | -239.25M | -225.71M | -206.26M | |||
All data in USD